aberrations and suit more than enough to tolerate FCR therapy, may still be fantastic candidates for the latter, With all the advantage becoming that this treatment is often accomplished in 6 months when ibrutinib has to be taken indefinitely.The disorder is always preceded by a premalignant condition (MBL) which shares most molecular drivers with